期刊文献+

原位心脏移植手术的体外循环管理 被引量:1

Management of Extracorporeal Circulation on Orthotopic Heart Transplantation
下载PDF
导出
摘要 目的总结探讨同种原位心脏移植手术体外循环管理的经验和方法.方法回顾分析2003年4月至今昆明医科大学附属延安医7例终末期心脏病患者的同种原位心脏移植手术.采用浅中低温、轻中度血液稀释、中高流量CPB体外循环,注重供体心肌保护,应用常规超滤与改良超滤技术,行多指标监测和临床观察.结果7例患者体外循环过程平稳,手术过程顺利.例1、例2和例5患者生存至今,已分别存活10 a、9 a和5 a;例3患者术后存活1 a;例4和例6患者死于移植术后右心衰、急性排斥反应;例7患者死于停机困难、严重低心排.结论进行良好的体外循环管理,合理选择供体心脏保护技术,减轻再灌注损伤和积极保护心肺功能是原位心脏移植手术体外循环管理的关键. Objective To explore an effective method for extracorporeal circulation on orthotopic heart transplantation.Methods Seven patients with end-stage heart disease who need orthotopic heart transplantation operation were retrospective analyzed in our hospital from 2003 April up to now.Shallow low and moderate temperature,mild-to-moderate blood dilution and high flow CBP extracorporeal circulation was used,cardiopulmonary l protection was emphasize,conventional ultrafiltration combined with modified ultrafiltration technology was applicated,and multiple clinical index were monitored and observed.Results Anesthesia process was stable,7 cases were operated successfully.The patients of cases 1,2 and 5 were survived until now(10,9 and 5 years,respectively).Case 3 was survived for 1 year.Cases 4 and 6 died of right heart failure after transplantation and acute rejection.Case 7 died of shutdown difficulties and severe low cardiac output.Conclusions Rational choice of cardiopulmonary protection method,effective management of extracorporeal circulation,active alleviation of reperfusion injury and protection of the heart-lung function are key factors for successfully extracorporeal circulation management on orthotopic heart transplantation.
出处 《昆明医科大学学报》 CAS 2013年第3期89-92,共4页 Journal of Kunming Medical University
基金 云南省科技厅科技计划基金资助项目(2007CA005)
关键词 原位心脏移植 体外循环 心肌保护 Orthotopic heart transplantation Extracorporeal circulation Cardiopulmonary protection
  • 相关文献

参考文献7

  • 1RUSSO M J,CHEN J M,SORABELLA R A, et al. The ef- fect of isehemie time on survival after heart transplantation varies by donor age: an analysis of the united network for organ sharing database [J]. J Thorac Cardiovasc Surg, 2007,133(2):554 - 559.
  • 2JOHNSON C E, FAULKNER S C,TUCKER J,et al. Opti- mizing cardioplegia slrategy for donor hearts [ J ]. Perfusion, 2004,19( 1 ):65 - 68.
  • 3OKADA Y,KONDO T. Impact of lung preservation solu- tions, euro-collins vs.low-potassium dextran, on early graft function: a review of five clinical studies [J ]. Ann Thorac Cardiovasc Surg,2006, 12( 1 ):10 - 14.
  • 4CAREAGA G,SALAZAR D,TELLEZ S,et al. Clinical i- mpact of histidine ketoglutarate tryptopham (HTK)cardio- plegic solution on the period in open heart surgery pa- tients [J]. Archives of Medical Research, 2001,32:296 - 299.
  • 5邢家林,龚庆成.康斯特保护液的心肌保护效果[J].中国体外循环杂志,2006,4(1):55-58. 被引量:11
  • 6丁文祥,苏肇伉,朱德明.小儿体外循环学[M].上海:上海世界图书出版公司,2009:406-7.
  • 7ROGERS K, OWENS T, GRIFFIN D A, et al. Extracorpo- real membrane oxygenation to cardiopulmonacy bypass with a single circuit exposure [J]. Perfusion,2005,20:295 - 298.

二级参考文献12

  • 1[1]Engelman RM ,Levitsky S.A textbook of Cardioplegia for Difficult Clinical Problems[J].Mount Kisco,NY ,Futura Publishing Company,Inc,1992:203.
  • 2[2]Jakob VJ.Myocardial Protection:An Overview[J].J Extra Corpor Technol,2000,32:38 - 47.
  • 3[3]Gebhard MM,Bretschneider HJ,Gersing E,et al.Calciumfree cardioplegia[J].Euro Heart J,1983,4 (Supplement H),151 - 160.
  • 4[4]Martin J,Lutter G,Ihling C,et al.Myocardial viability twentyfour hours after orthotopic heart transplantation from non - heartbeating donor[J].J Thorac Cardiovasc Surg ,2003,125:1217.
  • 5[5]Houischer M,Groenewoud AF.Current status of the HTK solution of Bretschneider in organ preservation [J].Transplantion Proc,1991,23:2334 -2337.
  • 6[6]Nido PJ,Wilson GJ,Mickle DA,et al.The role of cardioplegic solution buffering in myocardial protection[J].J Thorac Cardiovas Surg,1985,89:689 -699.
  • 7[7]Hachida M,Ookado A,Nonoyama M,et al.Effect of HTK solution for myocardial preservation[J].J Cardiovas Surg,1996,37:269 - 274.
  • 8[8]Kjellman UW,Bjork K,Ekroth R,et al.Addition of α - Ketoglutarate to Blood Cardioplegia Improves Cardio - protection[J].Ann Thorac Surg 1997,63:1625 - 1634.
  • 9[9]Preusse C J,Gebhard MM,Bretschneider H J:Myocardial "equilibration processes" and myocardial energy turnover during initiation of artificial cardiac arrest with cardioplegic solution:Reasons for a sufficiently long cardioplegic perfusion[J].Thorac Cardiovasc Surg 1981,29:71.
  • 10[10]Sakata J,Morishita K,Ito T,et al.Comparison of Clinical Outcome Between HTK solution and Cold Blood Cardioplegic Solution in Mitral Valve Replacement[J].J Card Surg ,1998,13:43 - 47.

共引文献14

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部